Dublin, Sept. 12, 2017 -- The "Substance Abuse, Addiction, and Treatment: Global Markets" report has been added to Research and Markets' offering.
The Global Substance Abuse and Addiction Treatment Market Should Reach Nearly $4.4 billion in 2021, at a CAGR of 7.0%
This report presents an in-depth analysis of the global substance abuse and addiction treatment market by conditions, treatments, and geographic markets; it includes the principal drug abuse conditions that are incorporated into several therapeutic treatment methods. This report examines the role of supply-chain members from manufacturers to researchers, and contains a comprehensive analysis of the dominant companies operating in the global substance abuse and addiction treatment market. The in-depth patent analysis section of the report will focus extensively on the technological trends across years and geographies such as the U.S., Europe and China.
This study considers the revenue generated by medications or therapeutics during the substance abuse treatment process. It does not review the expenses associated with services such as counseling, psychological therapy, rehabilitation or others. The report focuses on the substances that are either directly consumed or injected, hence the nicotine segment considers the medicines that help to treat smokeless tobacco addiction but does not take into account drugs that are only used for smoking cessation. The report examines all forms of opioids and cocaine in whichever form or mode they are ingested, and considers all types of alcohol abuse.
The market study is detailed for products based on applications as well as its further implication in the research and development area. These two segmentations are also discussed in depth for the given period.
Key market players operating in this market are Pfizer, GlaxoSmithKline, Alkermes, Teva Pharmaceuticals, Reckitt Benckiser, Forest Laboratories, and others totaling to about 20 companies.
Report Includes
- An overview of the global market for substance abuse and addiction treatment therapeutics
- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021
- Analyses of the market based on condition, treatment type, and region
- Discussion of the market dynamics, including drivers, restraints and opportunities
- An insight into the competitive landscape of the market through new product launches, mergers and acquisitions, and partnerships
- Profiles of the key players in the market
Key Topics Covered:
1: Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of the Report
- Intended Audience
- Information Sources and Methodology
- Geographic Breakdown
2: Summary and Highlights
- Table Summary : Global Market for Substance Abuse and Addiction Treatment, by Condition, Through 2021
- Figure Summary : Global Market for Substance Abuse and Addiction Treatment, by Condition, 2015-2021
3: Global Substance Abuse and Addiction Treatment Market and Technology Background
- Substance Abuse and Addiction Treatment
- Drug Testing Laws
- Testing Locations
- On-site Testing Versus Laboratory Testing
- Side Effects of Substance Abuse and Role of Drug Screening in Detection
- Drug, Nicotine and Alcohol Abuse Trends Among Youth
- Future Prediction of Drug Screening and Drug Abuse
- Technology Trends
- Government Funding for Drug Testing, Illicit Drug Use, Alcohol Use, and Other Parameters Influencing Market Growth
- Clinical Guidelines
- Overview of Captagon
- Market Dynamics
4: Global Substance Abuse and Addiction Treatment Market by Condition
- Nicotine Abuse
- Alcohol Abuse
- Drug Abuse
- Table 11 : Global Market for Substance Abuse and Addiction Treatment, by Condition, Through 2021
5: Global Substance Abuse and Addiction Treatment Market by Treatment Type
- Chantix
- Zyban
- Detoxification Treatment
- Campral
- Antabuse
- Methadone
- Suboxone
- Others
- Table 16 : Global Substance Abuse and Addiction Treatment Market, by Type, Through 2021
6: Global Substance Abuse and Addiction Treatment Market, Breakdown by Region
- North America
- Europe
- Asia-Pacific
- ROW
- Table 25 : Global Market for Substance Abuse and Addiction Treatment, by Region, Through 2021
7: Patent Review
- Patent Review by Year
- Patent Review by Region
- Patent Review by Applicant
- Patent Review for Substance Abuse
8: Global Substance Abuse and Addiction Treatment Market Opportunities Analysis
- Product Approval
- Collaborations
- Acquisitions
- Product Launches
- Figure 23 : Strategies for Global Substance Abuse and Addiction Treatment Market, 2014-2017
9: Company Profiles
- Alkermes Plc
- Allergan, Plc
- Celtic Pharma Holdings Advisors Llp
- Cipla Limited
- Consern Pharma Private Limited
- ELI Lilly And Company
- Glaxosmithkline Plc (Gsk)
- Intas Biopharmaceuticals
- Johnson & Johnson
- Mallinckrodt Pharmaceuticals
- Medtronic
- Novartis International AG
- Orasure Technologies
- Pfizer Inc.
- Psychemedics Corporation
- Purdue Pharma L.P.
- Reckitt Benckiser Group Plc
- Sun Pharmaceutical Industries Limited
- Takeda Pharmaceutical Company Ltd
- Teva Pharmaceuticals Industries Limited
10: Appendix: Lists of Patents
- List of Patents in North America
- List of Patents in Europe
- List of Patents in Asia-Pacific
- List of Patents in the ROW
- List of Abbreviations
For more information about this report visit https://www.researchandmarkets.com/research/9vjsjz/substance_abuse
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Addiction Disorders Drugs


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 



